PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Regenerative Medicine (IREM), Center for Therapy Development and Good Manufacturing Practice, University of Zurich, Zurich, Switzerland.\', \'Scientific IT Services ETH Zurich, ETH Zurich, Zürich, Switzerland.\', \'Center for Applied Biotechnology and Molecular Medicine (CABMM), University of Zurich, Zurich, Switzerland.\', \'Wyss Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.\', \'Department of Trauma Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/jcmm.17048
?:doi
?:hasPublicationType
?:journal
  • Journal of cellular and molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 34821008
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.647
?:rankingScore_hIndex
  • 108
?:title
  • Heterogeneous expression of ACE2 and TMPRRS2 in mesenchymal stromal cells.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34821008>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34821008>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all